• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CIAPIN1 的下调通过抑制 STAT3 通路调节乳腺癌细胞的增殖、迁移和糖酵解。

Downregulation of CIAPIN1 regulates the proliferation, migration and glycolysis of breast cancer cells via inhibition of STAT3 pathway.

机构信息

Department of Breast and Thyroid Surgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 2800 Gongwei Road, Pudong New Area, Shanghai, 201399, China.

Department of Pathology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China.

出版信息

Sci Rep. 2024 Sep 5;14(1):20794. doi: 10.1038/s41598-024-71405-3.

DOI:10.1038/s41598-024-71405-3
PMID:39242716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11379703/
Abstract

Cytokine-induced apoptosis inhibitor 1 (CIAPIN1) is a protein that regulates apoptosis and programmed cell death. This research aims to evaluate its potential role in inhibiting breast cancer cell proliferation, migration, and glycolysis and uncover its underlying molecular mechanism. We collected breast cancer tissue samples from eight patients between January 2019 and June 2023 in our Hospital to analyse CIAPIN1 expression. We transfected human breast cancer cell lines (MCF7, MDA-MB-231, MDA-MB-453, and MDA-MB-468) with siRNA of CIAPIN1. Finally, we determined protein expression using RT-qPCR and Western blotting. CIAPIN1 expression was elevated in both breast cancer tissue and serum. Overexpression of CIAPIN1 detected in the breast cancer cell lines MCF7 and MDA-MB-468. In addition, CIAPIN1 overexpression increased cell proliferation and migration rate. CIAPIN1 downregulation suppressed cell proliferation while elevated cellular apoptosis, reactive oxygen species (ROS) production and oxidative stress in breast cancer cells. Moreover, CIAPIN1 inhibition remarkably suppressed pyruvate, lactate and adenosine triphosphate (ATP) production and reduced the pyruvate kinase M2 (PKM2) protein expression and phosphorylation of signal transducer and activator of transcription 3 (STAT3) in breast cancer cells. Downregulation of CIAPIN1 suppresses cell proliferation, migration and glycolysis capacity in breast cancer cells by inhibiting the STAT3/PKM2 pathway.

摘要

细胞因子诱导凋亡抑制剂 1(CIAPIN1)是一种调节细胞凋亡和程序性细胞死亡的蛋白质。本研究旨在评估其抑制乳腺癌细胞增殖、迁移和糖酵解的潜力,并揭示其潜在的分子机制。我们从 2019 年 1 月至 2023 年 6 月在我院收集了 8 名乳腺癌患者的组织样本,以分析 CIAPIN1 的表达。我们用 CIAPIN1 的 siRNA 转染人乳腺癌细胞系(MCF7、MDA-MB-231、MDA-MB-453 和 MDA-MB-468)。最后,我们通过 RT-qPCR 和 Western blot 确定蛋白质表达。CIAPIN1 在乳腺癌组织和血清中表达上调。在 MCF7 和 MDA-MB-468 乳腺癌细胞系中检测到 CIAPIN1 的过表达。此外,CIAPIN1 过表达增加了细胞增殖和迁移率。CIAPIN1 下调抑制了乳腺癌细胞的增殖,同时增加了细胞凋亡、活性氧(ROS)产生和氧化应激。此外,CIAPIN1 抑制显著抑制了丙酮酸、乳酸和三磷酸腺苷(ATP)的产生,并降低了乳腺癌细胞中丙酮酸激酶 M2(PKM2)蛋白表达和信号转导和转录激活因子 3(STAT3)的磷酸化。下调 CIAPIN1 通过抑制 STAT3/PKM2 通路抑制乳腺癌细胞的增殖、迁移和糖酵解能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/968ee528ac57/41598_2024_71405_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/619dde563400/41598_2024_71405_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/a0906c077ca0/41598_2024_71405_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/a1f789a369c3/41598_2024_71405_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/b89e3fb44b5c/41598_2024_71405_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/45b6b7263c61/41598_2024_71405_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/75ff467edbbb/41598_2024_71405_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/5b4f3d5eb3e8/41598_2024_71405_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/cee35bd3df46/41598_2024_71405_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/968ee528ac57/41598_2024_71405_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/619dde563400/41598_2024_71405_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/a0906c077ca0/41598_2024_71405_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/a1f789a369c3/41598_2024_71405_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/b89e3fb44b5c/41598_2024_71405_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/45b6b7263c61/41598_2024_71405_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/75ff467edbbb/41598_2024_71405_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/5b4f3d5eb3e8/41598_2024_71405_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/cee35bd3df46/41598_2024_71405_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc94/11379703/968ee528ac57/41598_2024_71405_Fig9_HTML.jpg

相似文献

1
Downregulation of CIAPIN1 regulates the proliferation, migration and glycolysis of breast cancer cells via inhibition of STAT3 pathway.CIAPIN1 的下调通过抑制 STAT3 通路调节乳腺癌细胞的增殖、迁移和糖酵解。
Sci Rep. 2024 Sep 5;14(1):20794. doi: 10.1038/s41598-024-71405-3.
2
Lapatinib Inhibits Breast Cancer Cell Proliferation by Influencing PKM2 Expression.拉帕替尼通过影响丙酮酸激酶M2(PKM2)的表达来抑制乳腺癌细胞增殖。
Technol Cancer Res Treat. 2018 Jan 1;17:1533034617749418. doi: 10.1177/1533034617749418.
3
PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.PKM2 通过 let-7a-5p/Stat3/hnRNP-A1 调控反馈环促进乳腺癌细胞的糖代谢。
J Cell Biochem. 2019 Apr;120(4):6542-6554. doi: 10.1002/jcb.27947. Epub 2018 Oct 28.
4
Down regulation of CIAPIN1 reverses multidrug resistance in human breast cancer cells by inhibiting MDR1.下调 CIAPIN1 表达通过抑制 MDR1 逆转人乳腺癌细胞多药耐药性。
Molecules. 2012 Jun 20;17(6):7595-611. doi: 10.3390/molecules17067595.
5
CIAPIN1 targets Na⁺/H⁺ exchanger 1 to mediate MDA-MB-231 cells' metastasis through regulation of MMPs via ERK1/2 signaling pathway.CIAPIN1靶向Na⁺/H⁺交换蛋白1,通过ERK1/2信号通路调节基质金属蛋白酶,介导MDA-MB-231细胞的转移。
Exp Cell Res. 2015 Apr 10;333(1):60-72. doi: 10.1016/j.yexcr.2015.02.012. Epub 2015 Feb 24.
6
Cytokine-induced apoptosis inhibitor 1 inhibits the growth and proliferation of multiple myeloma.细胞因子诱导的凋亡抑制剂1抑制多发性骨髓瘤的生长和增殖。
Mol Med Rep. 2015 Aug;12(2):2056-62. doi: 10.3892/mmr.2015.3656. Epub 2015 Apr 22.
7
Rho GTPase Activating Protein 24 (ARHGAP24) Regulates the Anti-Cancer Activity of Sorafenib Against Breast Cancer MDA-MB-231 Cells via the Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway.Rho GTP 酶激活蛋白 24(ARHGAP24)通过信号转导子和转录激活子 3(STAT3)信号通路调节索拉非尼对乳腺癌 MDA-MB-231 细胞的抗癌活性。
Med Sci Monit. 2018 Nov 30;24:8669-8677. doi: 10.12659/MSM.911394.
8
Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells.新型索拉非尼类似物通过依赖SHP-1的STAT3失活诱导人乳腺癌细胞凋亡。
Breast Cancer Res. 2013;15(4):R63. doi: 10.1186/bcr3457.
9
I157172, a novel inhibitor of cystathionine γ-lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3.I157172 是一种新型胱硫醚 γ-裂解酶抑制剂,通过 SIRT1 介导的 STAT3 去乙酰化来抑制乳腺癌细胞的生长和迁移。
Oncol Rep. 2019 Jan;41(1):427-436. doi: 10.3892/or.2018.6798. Epub 2018 Oct 16.
10
Atiprimod triggered apoptotic cell death via acting on PERK/eIF2α/ATF4/CHOP and STAT3/NF-ΚB axis in MDA-MB-231 and MDA-MB-468 breast cancer cells.阿替利珠单抗通过作用于 PERK/eIF2α/ATF4/CHOP 和 STAT3/NF-ΚB 轴诱导 MDA-MB-231 和 MDA-MB-468 乳腺癌细胞凋亡。
Mol Biol Rep. 2021 Jun;48(6):5233-5247. doi: 10.1007/s11033-021-06528-1. Epub 2021 Jul 9.

本文引用的文献

1
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism.m6A 调控的肿瘤糖酵解:表观遗传学和代谢领域的新进展。
Mol Cancer. 2023 Aug 15;22(1):137. doi: 10.1186/s12943-023-01841-8.
2
circ_0058063 promotes breast cancer progression by upregulating DLGAP5 via sponging miR-557.circ_0058063 通过海绵吸附 miR-557 而上调 DLGAP5 促进乳腺癌进展。
Cancer Biomark. 2024;39(1):1-13. doi: 10.3233/CBM-220410.
3
ANGPTL4 suppresses the profibrogenic functions of atrial fibroblasts induced by angiotensin II by up-regulating PPARγ.
血管生成素样蛋白4通过上调过氧化物酶体增殖物激活受体γ来抑制血管紧张素II诱导的心房成纤维细胞的促纤维化功能。
Iran J Basic Med Sci. 2023;26(5):587-593. doi: 10.22038/IJBMS.2023.69196.15077.
4
Relative Survival With Early-Stage Breast Cancer in Screened and Unscreened Populations.早期乳腺癌在筛查人群和非筛查人群中的相对生存率。
Mayo Clin Proc. 2022 Dec;97(12):2316-2323. doi: 10.1016/j.mayocp.2022.08.006. Epub 2022 Nov 3.
5
MicroRNA-409-5p inhibits cell proliferation, and induces G/M phase arrest and apoptosis by targeting DLGAP5 in ovarian cancer cells.微小RNA-409-5p通过靶向卵巢癌细胞中的DLGAP5抑制细胞增殖,并诱导G/M期阻滞和细胞凋亡。
Oncol Lett. 2022 Jun 14;24(2):261. doi: 10.3892/ol.2022.13381. eCollection 2022 Aug.
6
Ultrasound and Photoacoustic Imaging of Breast Cancer: Clinical Systems, Challenges, and Future Outlook.乳腺癌的超声与光声成像:临床系统、挑战及未来展望
J Clin Med. 2022 Feb 22;11(5):1165. doi: 10.3390/jcm11051165.
7
STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications.STAT3 作为致癌细胞代谢的介质:发病机制和治疗意义。
Neoplasia. 2021 Dec;23(12):1167-1178. doi: 10.1016/j.neo.2021.10.003. Epub 2021 Oct 29.
8
Pan-cancer analysis and experiments with cell lines reveal that the slightly elevated expression of DLGAP5 is involved in clear cell renal cell carcinoma progression.泛癌症分析和细胞系实验表明,DLGAP5 的轻度升高表达与透明细胞肾细胞癌的进展有关。
Life Sci. 2021 Dec 15;287:120056. doi: 10.1016/j.lfs.2021.120056. Epub 2021 Oct 20.
9
Magnetic resonance imaging before breast cancer surgery: results of an observational multicenter international prospective analysis (MIPA).乳腺癌术前磁共振成像:一项观察性多中心国际前瞻性分析(MIPA)的结果。
Eur Radiol. 2022 Mar;32(3):1611-1623. doi: 10.1007/s00330-021-08240-x. Epub 2021 Oct 13.
10
Sperm-Specific Glycolysis Enzyme Glyceraldehyde-3-Phosphate Dehydrogenase Regulated by Transcription Factor SOX10 to Promote Uveal Melanoma Tumorigenesis.精子特异性糖酵解酶甘油醛-3-磷酸脱氢酶受转录因子SOX10调控以促进葡萄膜黑色素瘤肿瘤发生。
Front Cell Dev Biol. 2021 Jun 25;9:610683. doi: 10.3389/fcell.2021.610683. eCollection 2021.